Skip to main content

Table 1 Factors associated with tuberculosis among PLHIV between 2006 and 2011

From: A comparision of the yield of three tuberculosis screening modalities among people living with HIV: a retrospective quasi-experiemental study

Variable All cohort TB No TB Univariate Multivariate
N = 2,458 (100) n = 275 (11.18) n = 2,183 (88.81) OR 95 % CI P–value aOR 95 % CI P–value
Age (years)
Mean (sd) 34.8 (11.5) 38.0 (11.7) 34.4 (11.5) 1.02 1.01 – 1.04 <0.001 1.03 1.01 – 1.03 <0.001
Gender
Female 1,505 (61.2) 175 (63.6) 1,329 (60.9) 1   0.38    
Male 953 (38.7) 100 (36.4) 854 (39.1) 1.13 0.87 – 1.46   - - -
Education#
None 501 (21.8) 40 (15) 461 (22.7) 1   <0.001 1   
Primary 993 (43.2) 134 (50.4) 859 (42.3) 1.80 124 – 2.61   1.72 1.18 – 2.51 0.005
Secondary 654 (28.5) 62 (23.3) 592 (29.1) 1.20 0.79 – 1.83   1.22 0.80 – 1.86 0.350
Tertiary 149 (6.5) 30 (11.3) 119 (5.9) 2.90 1.73 – 4.86   2.38 1.41 – 4.04 0.001
Missing 161 (6.5) 9 (3.27 %) 152 (6.96 %)       
ART Status
No 546 (22) 22 (8) 524 (24) 1   <0.001 1   
Yes 1912 (78) 253 (92) 1659 (76) 3.64 2.32–5.71   3.38 2.16 – 5.32 <0.001
Baseline CD4+
Median (IQR) 505 (200–720) 552 (286–782) 496 (192–712) 1.00 1.00.–1.00 <0.01 1.00 1.00 – 1.00 0.034
BMI
Mean (sd) 24.9 (5) 26.1 (5.3) 24.2 (4.9) 1.05 1.03–1.08 <0.001 1.05 1.02 – 1.07 0.001
  1. Abbreviations: ART antiretroviral therapy, aOR odds ratio adjusted for all variables with p < 0.25, BMI basal mass index, CD4+ cluster of differentiation, CI confidence interval, OR crude odds ratio, IQR inter quartile range, sd standard deviation, TB Tuberculosis, *Significance level of p < 0.05, () refers to percentage unless stated